Valeant names Joseph C. Papa as new chairman, CEO

Valeant Pharmaceuticals International announced in a press release that its board of directors has named Joseph C. Papa as Valeant’s chairman and CEO.Papa, chairman and CEO of Perrigo Company plc, a global health care supplier that develops and distributes over-the-counter and prescription pharmaceuticals, is expected to begin his new position in early May, according to the release. He will succeed J. Michael Pearson, who is expected to remain as CEO and a director until Papa begins at Valeant, the release reported.